Novel patch for transdermal administration of morphine

Journal of Pain and Symptom Management

Volumn 44, Issue 4, 2012, Pages 479-485

  Inui, Naoki ^a   Kato, Tatsuhisa ^b   Uchida, Shinya ^a   Chida, Kingo ^a   Takeuchi, Kazuhiko ^a   Kimura, Takahito ^b   Watanabe, Hiroshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Teika Pharmaceutical Company Limited   (Japan)

Author keywords

Morphine; Pharmacokinetics; Transdermal administration

Indexed keywords

CHLORIDE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; POLYETHYLENE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; SKIN REDNESS; SKIN SWELLING; TRANSDERMAL PATCH;

EID: 84869224641     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.10.022     Document Type: Article

References (22)

1. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA 1995;274: 1870-1873. (Pubitemid 26001265)
2. Quigley C. The role of opioids in cancer pain. BMJ 2005;331:825-829. (Pubitemid 41442365)
3. Jost L, Roila F. Management of cancer pain: ESMO clinical recommendations. Ann Oncol 2008;19(Suppl 2):ii119eii121.
4. Quigley C. Opioids in people with cancerrelated pain. Clin Evid (Online) 2008;2008:pii:2408.
5. Calis KA, Kohler DR, Corso DM. Transdermally administered fentanyl for pain management. Clin Pharm 1992;11:22-36.
6. Indelicato RA, Portenoy RK. Opioid rotation in the management of refractory cancer pain. J Clin Oncol 2002;20:348-352. (Pubitemid 34032631)
7. Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev 2006; 32:304-315. (Pubitemid 44502005)
8. Varvel JR, Shafer SL, Hwang SS, Coen PA, Stanski DR. Absorption characteristics of transdermally administered fentanyl. Anesthesiology 1989; 70:928-934. (Pubitemid 19148495)
9. Kress HG. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain 2009;13:219-230.
10. Seibel PS, Barrett CW, Kirk CJ, Heykants J. Transdermal absorption of fentanyl and sufentanil in man. Eur J Clin Pharmacol 1987;32:529-531. (Pubitemid 17096201)
11. Paice JA, Von Roenn JH, Hudgins JC, et al. Morphine bioavailability from a topical gel formulation in volunteers. J Pain Symptom Manage 2008;35: 314-320. (Pubitemid 351273535)
12. Wang JJ, Sung KC, Huang JF, Yeh CH, Fang JY. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study. J Pharm Pharmacol 2007;59:917-925. (Pubitemid 47051071)
13. Sawe J, Kager L, Svensson Eng JO, Rane A. Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. Br J Clin Pharmacol 1985;19:495-501. (Pubitemid 16254591)
14. Osborne R, Joel S, Trew D, Slevin M. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 1990;47:12-19. (Pubitemid 20041204)
15. Stuart-Harris R, Joel SP, McDonald P, Currow D, Slevin ML. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Br J Clin Pharmacol 2000;49: 207-214. (Pubitemid 30150981)
16. Gourlay GK, Kowalski SR, Plummer JL, et al. The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects. Pain 1989;37: 193-202. (Pubitemid 19136147)
17. Roy SD, Flynn GL. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm Res 1989;6:825-832. (Pubitemid 20012231)
18. Tennant F, Moll D, DePaulo V. Topical morphine for peripheral pain. Lancet 1993;342: 1047-1048.
19. Westerling D, Hoglund P, Lundin S, Svedman P. Transdermal administration of morphine to healthy subjects. Br J Clin Pharmacol 1994;37:571-576. (Pubitemid 24197151)
20. Ribeiro MD, Joel SP, Zeppetella G. The bioavailability of morphine applied topically to cutaneous ulcers. J Pain Symptom Manage 2004; 27:434-439. (Pubitemid 38569649)
21. Krajnik M, Zylicz Z, Finlay I, Luczak J, van Sorge AA. Potential uses of topical opioids in palliative caredreport of 6 cases. Pain 1999;80:121-125. (Pubitemid 29151696)
22. Twillman RK, Long TD, Cathers TA, Mueller DW. Treatment of painful skin ulcers with topical opioids. J Pain Symptom Manage 1999;17: 288-292. (Pubitemid 29159971)